XML 23 R12.htm IDEA: XBRL DOCUMENT v3.4.0.3
Accumulated Other Comprehensive Income (Loss)
 9 Months Ended
Apr. 02, 2016
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss)
Note 5. Accumulated Other Comprehensive Income (Loss)
The Company’s accumulated other comprehensive income (loss) consists of the accumulated net unrealized gains and losses on available-for-sale investments, foreign currency translation adjustments and defined benefit obligations.
For the nine months ended April 2, 2016 the changes in accumulated other comprehensive income (loss) by component net of tax were as follows (in millions):
 
Unrealized (losses) on available-for sale investments (2)
 
Foreign 
currency translation adjustments
 
Defined benefit obligation, net of tax (3)
 
Total
Beginning balance as of June 27, 2015
$
(3.2
)
 
$
(29.2
)
 
$
(15.6
)
 
$
(48.0
)
Transferred to Lumentum (1)
—

 
(8.9
)
 
1.1

 
(7.8
)
Other comprehensive (loss) income before reclassification
201.6

 
(18.4
)
 
—

 
183.2

Amounts reclassified from accumulated other comprehensive income (loss)
(38.8
)
 
—

 
0.5

 
(38.3
)
Net current-period other comprehensive (loss) income
162.8

 
(18.4
)
 
0.5

 
144.9

Ending balance as of April 2, 2016
$
159.6

 
$
(56.5
)
 
$
(14.0
)
 
$
89.1


(1) Amount represents the transfer of accumulated other comprehensive balances to Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information.

(2) Activity before reclassifications to the Consolidated Statements of Operations during the nine months ended April 2, 2016 primarily relates to a $205.3 million gross unrealized gain on the marketable equity securities of Lumentum held by Viavi, net of a $3.7 million income tax effect related to the intraperiod tax allocation rules. The amount reclassified out of accumulated other comprehensive income (loss) is primarily composed of a $39.7 million realized gain before tax during the three months ended April 2, 2016 from the sale of 2.5 million shares out of 11.7 million shares of the marketable equity securities of Lumentum held by Viavi upon Separation, net of a $1.0 million income tax effect related to the intraperiod tax allocation rules. The gain and the income tax effect are included in "Gain on sale of investments" and “Provision for income taxes,” respectively, in the Consolidated Statement of Operations for the three and nine months ended April 2, 2016.

(3) Amount represents the amortization of actuarial losses included as a component of Selling, general and administrative expense (“SG&A”) in the Consolidated Statement of Operations for the nine months ended April 2, 2016. There was no tax impact. Refer to “Note 15. Employee Pension and Other Benefit Plans” for more details on the computation of net periodic cost for pension plans.